IBDEI3GU ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58294,0)
;;=E09.359^^272^2905^30
;;^UTILITY(U,$J,358.3,58294,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58294,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58294,1,4,0)
;;=4^E09.359
;;^UTILITY(U,$J,358.3,58294,2)
;;=^5002561
;;^UTILITY(U,$J,358.3,58295,0)
;;=H52.4^^272^2906^57
;;^UTILITY(U,$J,358.3,58295,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58295,1,3,0)
;;=3^Presbyopia
;;^UTILITY(U,$J,358.3,58295,1,4,0)
;;=4^H52.4
;;^UTILITY(U,$J,358.3,58295,2)
;;=^98095
;;^UTILITY(U,$J,358.3,58296,0)
;;=H01.004^^272^2906^6
;;^UTILITY(U,$J,358.3,58296,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58296,1,3,0)
;;=3^Blepharitis,Left Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58296,1,4,0)
;;=4^H01.004
;;^UTILITY(U,$J,358.3,58296,2)
;;=^5004241
;;^UTILITY(U,$J,358.3,58297,0)
;;=H01.005^^272^2906^5
;;^UTILITY(U,$J,358.3,58297,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58297,1,3,0)
;;=3^Blepharitis,Left Lower Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58297,1,4,0)
;;=4^H01.005
;;^UTILITY(U,$J,358.3,58297,2)
;;=^5133380
;;^UTILITY(U,$J,358.3,58298,0)
;;=H02.105^^272^2906^24
;;^UTILITY(U,$J,358.3,58298,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58298,1,3,0)
;;=3^Ectropion,Left Lower Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58298,1,4,0)
;;=4^H02.105
;;^UTILITY(U,$J,358.3,58298,2)
;;=^5133409
;;^UTILITY(U,$J,358.3,58299,0)
;;=H02.104^^272^2906^25
;;^UTILITY(U,$J,358.3,58299,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58299,1,3,0)
;;=3^Ectropion,Left Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58299,1,4,0)
;;=4^H02.104
;;^UTILITY(U,$J,358.3,58299,2)
;;=^5004305
;;^UTILITY(U,$J,358.3,58300,0)
;;=H02.101^^272^2906^27
;;^UTILITY(U,$J,358.3,58300,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58300,1,3,0)
;;=3^Ectropion,Right Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58300,1,4,0)
;;=4^H02.101
;;^UTILITY(U,$J,358.3,58300,2)
;;=^5004303
;;^UTILITY(U,$J,358.3,58301,0)
;;=H02.102^^272^2906^26
;;^UTILITY(U,$J,358.3,58301,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58301,1,3,0)
;;=3^Ectropion,Right Lower Eyelid,Unspec
;;^UTILITY(U,$J,358.3,58301,1,4,0)
;;=4^H02.102
;;^UTILITY(U,$J,358.3,58301,2)
;;=^5133407
;;^UTILITY(U,$J,358.3,58302,0)
;;=H04.121^^272^2906^23
;;^UTILITY(U,$J,358.3,58302,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58302,1,3,0)
;;=3^Dry Eye Syndrome,Right Lacrimal Gland
;;^UTILITY(U,$J,358.3,58302,1,4,0)
;;=4^H04.121
;;^UTILITY(U,$J,358.3,58302,2)
;;=^5004463
;;^UTILITY(U,$J,358.3,58303,0)
;;=H04.122^^272^2906^22
;;^UTILITY(U,$J,358.3,58303,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58303,1,3,0)
;;=3^Dry Eye Syndrome,Left Lacrimal Gland
;;^UTILITY(U,$J,358.3,58303,1,4,0)
;;=4^H04.122
;;^UTILITY(U,$J,358.3,58303,2)
;;=^5004464
;;^UTILITY(U,$J,358.3,58304,0)
;;=H43.811^^272^2906^80
;;^UTILITY(U,$J,358.3,58304,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58304,1,3,0)
;;=3^Vitreous Degeneration,Right Eye
;;^UTILITY(U,$J,358.3,58304,1,4,0)
;;=4^H43.811
;;^UTILITY(U,$J,358.3,58304,2)
;;=^5005953
;;^UTILITY(U,$J,358.3,58305,0)
;;=H43.812^^272^2906^79
;;^UTILITY(U,$J,358.3,58305,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58305,1,3,0)
;;=3^Vitreous Degeneration,Left Eye
;;^UTILITY(U,$J,358.3,58305,1,4,0)
;;=4^H43.812
;;^UTILITY(U,$J,358.3,58305,2)
;;=^5005954
;;^UTILITY(U,$J,358.3,58306,0)
;;=H25.89^^272^2906^9
;;^UTILITY(U,$J,358.3,58306,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58306,1,3,0)
;;=3^Cataract,Age-Related NEC
;;^UTILITY(U,$J,358.3,58306,1,4,0)
;;=4^H25.89
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GU 3979 printed Sep 23, 2025@20:24:33 Page 2
IBDEI3GU ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58294,0)
+2 ;;=E09.359^^272^2905^30
+3 ;;^UTILITY(U,$J,358.3,58294,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,58294,1,3,0)
+6 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/o Macular Edema
+7 ;;^UTILITY(U,$J,358.3,58294,1,4,0)
+8 ;;=4^E09.359
+9 ;;^UTILITY(U,$J,358.3,58294,2)
+10 ;;=^5002561
+11 ;;^UTILITY(U,$J,358.3,58295,0)
+12 ;;=H52.4^^272^2906^57
+13 ;;^UTILITY(U,$J,358.3,58295,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,58295,1,3,0)
+16 ;;=3^Presbyopia
+17 ;;^UTILITY(U,$J,358.3,58295,1,4,0)
+18 ;;=4^H52.4
+19 ;;^UTILITY(U,$J,358.3,58295,2)
+20 ;;=^98095
+21 ;;^UTILITY(U,$J,358.3,58296,0)
+22 ;;=H01.004^^272^2906^6
+23 ;;^UTILITY(U,$J,358.3,58296,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,58296,1,3,0)
+26 ;;=3^Blepharitis,Left Upper Eyelid,Unspec
+27 ;;^UTILITY(U,$J,358.3,58296,1,4,0)
+28 ;;=4^H01.004
+29 ;;^UTILITY(U,$J,358.3,58296,2)
+30 ;;=^5004241
+31 ;;^UTILITY(U,$J,358.3,58297,0)
+32 ;;=H01.005^^272^2906^5
+33 ;;^UTILITY(U,$J,358.3,58297,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,58297,1,3,0)
+36 ;;=3^Blepharitis,Left Lower Eyelid,Unspec
+37 ;;^UTILITY(U,$J,358.3,58297,1,4,0)
+38 ;;=4^H01.005
+39 ;;^UTILITY(U,$J,358.3,58297,2)
+40 ;;=^5133380
+41 ;;^UTILITY(U,$J,358.3,58298,0)
+42 ;;=H02.105^^272^2906^24
+43 ;;^UTILITY(U,$J,358.3,58298,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,58298,1,3,0)
+46 ;;=3^Ectropion,Left Lower Eyelid,Unspec
+47 ;;^UTILITY(U,$J,358.3,58298,1,4,0)
+48 ;;=4^H02.105
+49 ;;^UTILITY(U,$J,358.3,58298,2)
+50 ;;=^5133409
+51 ;;^UTILITY(U,$J,358.3,58299,0)
+52 ;;=H02.104^^272^2906^25
+53 ;;^UTILITY(U,$J,358.3,58299,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,58299,1,3,0)
+56 ;;=3^Ectropion,Left Upper Eyelid,Unspec
+57 ;;^UTILITY(U,$J,358.3,58299,1,4,0)
+58 ;;=4^H02.104
+59 ;;^UTILITY(U,$J,358.3,58299,2)
+60 ;;=^5004305
+61 ;;^UTILITY(U,$J,358.3,58300,0)
+62 ;;=H02.101^^272^2906^27
+63 ;;^UTILITY(U,$J,358.3,58300,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,58300,1,3,0)
+66 ;;=3^Ectropion,Right Upper Eyelid,Unspec
+67 ;;^UTILITY(U,$J,358.3,58300,1,4,0)
+68 ;;=4^H02.101
+69 ;;^UTILITY(U,$J,358.3,58300,2)
+70 ;;=^5004303
+71 ;;^UTILITY(U,$J,358.3,58301,0)
+72 ;;=H02.102^^272^2906^26
+73 ;;^UTILITY(U,$J,358.3,58301,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,58301,1,3,0)
+76 ;;=3^Ectropion,Right Lower Eyelid,Unspec
+77 ;;^UTILITY(U,$J,358.3,58301,1,4,0)
+78 ;;=4^H02.102
+79 ;;^UTILITY(U,$J,358.3,58301,2)
+80 ;;=^5133407
+81 ;;^UTILITY(U,$J,358.3,58302,0)
+82 ;;=H04.121^^272^2906^23
+83 ;;^UTILITY(U,$J,358.3,58302,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,58302,1,3,0)
+86 ;;=3^Dry Eye Syndrome,Right Lacrimal Gland
+87 ;;^UTILITY(U,$J,358.3,58302,1,4,0)
+88 ;;=4^H04.121
+89 ;;^UTILITY(U,$J,358.3,58302,2)
+90 ;;=^5004463
+91 ;;^UTILITY(U,$J,358.3,58303,0)
+92 ;;=H04.122^^272^2906^22
+93 ;;^UTILITY(U,$J,358.3,58303,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,58303,1,3,0)
+96 ;;=3^Dry Eye Syndrome,Left Lacrimal Gland
+97 ;;^UTILITY(U,$J,358.3,58303,1,4,0)
+98 ;;=4^H04.122
+99 ;;^UTILITY(U,$J,358.3,58303,2)
+100 ;;=^5004464
+101 ;;^UTILITY(U,$J,358.3,58304,0)
+102 ;;=H43.811^^272^2906^80
+103 ;;^UTILITY(U,$J,358.3,58304,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,58304,1,3,0)
+106 ;;=3^Vitreous Degeneration,Right Eye
+107 ;;^UTILITY(U,$J,358.3,58304,1,4,0)
+108 ;;=4^H43.811
+109 ;;^UTILITY(U,$J,358.3,58304,2)
+110 ;;=^5005953
+111 ;;^UTILITY(U,$J,358.3,58305,0)
+112 ;;=H43.812^^272^2906^79
+113 ;;^UTILITY(U,$J,358.3,58305,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,58305,1,3,0)
+116 ;;=3^Vitreous Degeneration,Left Eye
+117 ;;^UTILITY(U,$J,358.3,58305,1,4,0)
+118 ;;=4^H43.812
+119 ;;^UTILITY(U,$J,358.3,58305,2)
+120 ;;=^5005954
+121 ;;^UTILITY(U,$J,358.3,58306,0)
+122 ;;=H25.89^^272^2906^9
+123 ;;^UTILITY(U,$J,358.3,58306,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,58306,1,3,0)
+126 ;;=3^Cataract,Age-Related NEC
+127 ;;^UTILITY(U,$J,358.3,58306,1,4,0)
+128 ;;=4^H25.89
